Drug discovery for schizophrenia. (2015)

• Record Type: Book
• Further Information: Note: Edited by Tatiana V. Lipina, Institute of Physiology, Novosibirsk, Russia, John C. Roder, Lumenfeld-Tanenbaum Research Institute, Toronto, Canada.
• Editors: Lipina, Tatiana V; Roder, John C
• Other Names: Royal Society of Chemistry (Great Britain), issuing body.
• Contents: Genetics of schizophrenia: Genome-Wide Association Study; Epigenetics of schizophrenia; Cognitive dysfunction in schizophrenia; Modelling schizophrenia; Glutamate hypothesis of schizophrenia; Dopamine hypothesis of schizophrenia; Neurodevelopmental hypothesis of schizophrenia; Genetic factors and hippocampal dysfunction in schizophrenia; Exome study of schizophrenia; Protein-protein interactions as a potentially new drug target in schizophrenia; Optogenetic approach to dissect neurobiology of schizophrenia; MicroRNAs in neuronal function and dysfunction; Application of pluripotent stem cells in schizophrenia; Deep brain stimulation of the hippocampus and prefrontal cortex as alternative approach in treatment of schizophrenia; Neuroimmunology of brain development in schizophrenia and immunotherapy
• Publisher Details: Cambridge : Royal Society of Chemistry
• Publication Date: 2015
• Extent: 1 online resource
• Subjects: 616.89/8061; MEDICAL / Pharmacology; Drugs -- Design; Schizophrenia -- Chemotherapy; SCIENCE / Life Sciences / Biochemistry; Psychiatry; Chemistry; Schizophrenia -- Chemotherapy; Drugs -- Design; Schizophrenia -- drug therapy; Drug Discovery; Antipsychotic Agents
• Languages: English
• ISBNs: 9781782622499; 1782622497
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.